There is provided topical pharmaceutical formulations comprising montelukast，or a pharmaceutical acceptable salt of solvate thereof，as well as combination products comprising（a）at least one mussel adhesive protein or a derivative thereof；and（b）montelukast，or a pharmaceutically-acceptable salt or solvate thereof．The formulations and combination products find particular utility in direct topical administration for the treatment of inflammation，of inflammatory disorders and/or of condition characterized by inflammation，including wounds，burns， psoriasis，acne and atopic dermatitis.
